Skip to main content

Risks and Rewards of Accelerated FDA Pathways

Mintz Levin


Date: March 29, 2018

Time: 4:30PM

Location: Boston, MA

Mintz Levin's Bethany Hills will moderate a panel on "Risks and Rewards of Accelerated FDA Pathways" at the Analysis Group and Mintz Levin's FDA event. Topics that will be covered include: 

  • When to consider an alternative pathway to approval
  • Risks including the chance of FDA denial
  • Market perceptions — increased value, rising stock prices
  • Realities of the pathways
  • Clinical and data risks
  • Pairing exclusivity and accelerated pathways
  • Finance theory on risk and stock pricing

Register for Event


Professional Hills Bethany Mintz

Bethany J. Hills


Bethany J. Hills is recognized for her experience and insight on FDA matters. At Mintz, she advises health care providers on pre- and post-market issues. Bethany also helps international and US companies enter and navigate the US health care market.